Copyright Reports & Markets. All rights reserved.

Global Autoimmune Disorder Drug Delivery Device Market Research Report 2021

Request for Sample of this report
Buy now

1 Autoimmune Disorder Drug Delivery Device Market Overview

  • 1.1 Product Overview and Scope of Autoimmune Disorder Drug Delivery Device
  • 1.2 Autoimmune Disorder Drug Delivery Device Segment by Type
    • 1.2.1 Global Autoimmune Disorder Drug Delivery Device Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Pen Injectors
    • 1.2.3 Auto-Injectors
    • 1.2.4 Prefilled Syringes
    • 1.2.5 Vials
  • 1.3 Autoimmune Disorder Drug Delivery Device Segment by Application
    • 1.3.1 Autoimmune Disorder Drug Delivery Device Sales Comparison by Application: (2021-2027)
    • 1.3.2 In-house Manufacturing
    • 1.3.3 Outsourced Manufacturing
  • 1.4 Global Autoimmune Disorder Drug Delivery Device Market Size Estimates and Forecasts
    • 1.4.1 Global Autoimmune Disorder Drug Delivery Device Revenue 2016-2027
    • 1.4.2 Global Autoimmune Disorder Drug Delivery Device Sales 2016-2027
    • 1.4.3 Autoimmune Disorder Drug Delivery Device Market Size by Region: 2016 Versus 2021 Versus 2027

2 Autoimmune Disorder Drug Delivery Device Market Competition by Manufacturers

  • 2.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Autoimmune Disorder Drug Delivery Device Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Autoimmune Disorder Drug Delivery Device Manufacturing Sites, Area Served, Product Type
  • 2.5 Autoimmune Disorder Drug Delivery Device Market Competitive Situation and Trends
    • 2.5.1 Autoimmune Disorder Drug Delivery Device Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Autoimmune Disorder Drug Delivery Device Players Market Share by Revenue
    • 2.5.3 Global Autoimmune Disorder Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Autoimmune Disorder Drug Delivery Device Retrospective Market Scenario by Region

  • 3.1 Global Autoimmune Disorder Drug Delivery Device Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Autoimmune Disorder Drug Delivery Device Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
    • 3.3.1 North America Autoimmune Disorder Drug Delivery Device Sales by Country
    • 3.3.2 North America Autoimmune Disorder Drug Delivery Device Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
    • 3.4.1 Europe Autoimmune Disorder Drug Delivery Device Sales by Country
    • 3.4.2 Europe Autoimmune Disorder Drug Delivery Device Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Autoimmune Disorder Drug Delivery Device Sales by Region
    • 3.5.2 Asia Pacific Autoimmune Disorder Drug Delivery Device Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
    • 3.6.1 Latin America Autoimmune Disorder Drug Delivery Device Sales by Country
    • 3.6.2 Latin America Autoimmune Disorder Drug Delivery Device Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Autoimmune Disorder Drug Delivery Device Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Autoimmune Disorder Drug Delivery Device Sales by Country
    • 3.7.2 Middle East and Africa Autoimmune Disorder Drug Delivery Device Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Autoimmune Disorder Drug Delivery Device Historic Market Analysis by Type

  • 4.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Type (2016-2021)
  • 4.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Type (2016-2021)
  • 4.3 Global Autoimmune Disorder Drug Delivery Device Price by Type (2016-2021)

5 Global Autoimmune Disorder Drug Delivery Device Historic Market Analysis by Application

  • 5.1 Global Autoimmune Disorder Drug Delivery Device Sales Market Share by Application (2016-2021)
  • 5.2 Global Autoimmune Disorder Drug Delivery Device Revenue Market Share by Application (2016-2021)
  • 5.3 Global Autoimmune Disorder Drug Delivery Device Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 AbbVie Inc.
    • 6.1.1 AbbVie Inc. Corporation Information
    • 6.1.2 AbbVie Inc. Description and Business Overview
    • 6.1.3 AbbVie Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 AbbVie Inc. Product Portfolio
    • 6.1.5 AbbVie Inc. Recent Developments/Updates
  • 6.2 Amgen Inc.
    • 6.2.1 Amgen Inc. Corporation Information
    • 6.2.2 Amgen Inc. Description and Business Overview
    • 6.2.3 Amgen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Amgen Inc. Product Portfolio
    • 6.2.5 Amgen Inc. Recent Developments/Updates
  • 6.3 F. Hoffmann- La Roche Ltd.
    • 6.3.1 F. Hoffmann- La Roche Ltd. Corporation Information
    • 6.3.2 F. Hoffmann- La Roche Ltd. Description and Business Overview
    • 6.3.3 F. Hoffmann- La Roche Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 F. Hoffmann- La Roche Ltd. Product Portfolio
    • 6.3.5 F. Hoffmann- La Roche Ltd. Recent Developments/Updates
  • 6.4 Novartis AG
    • 6.4.1 Novartis AG Corporation Information
    • 6.4.2 Novartis AG Description and Business Overview
    • 6.4.3 Novartis AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Novartis AG Product Portfolio
    • 6.4.5 Novartis AG Recent Developments/Updates
  • 6.5 GlaxoSmithKline Plc
    • 6.5.1 GlaxoSmithKline Plc Corporation Information
    • 6.5.2 GlaxoSmithKline Plc Description and Business Overview
    • 6.5.3 GlaxoSmithKline Plc Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 GlaxoSmithKline Plc Product Portfolio
    • 6.5.5 GlaxoSmithKline Plc Recent Developments/Updates
  • 6.6 Biogen Inc.
    • 6.6.1 Biogen Inc. Corporation Information
    • 6.6.2 Biogen Inc. Description and Business Overview
    • 6.6.3 Biogen Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Biogen Inc. Product Portfolio
    • 6.6.5 Biogen Inc. Recent Developments/Updates
  • 6.7 Merck KGaA
    • 6.6.1 Merck KGaA Corporation Information
    • 6.6.2 Merck KGaA Description and Business Overview
    • 6.6.3 Merck KGaA Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merck KGaA Product Portfolio
    • 6.7.5 Merck KGaA Recent Developments/Updates
  • 6.8 Bayer AG
    • 6.8.1 Bayer AG Corporation Information
    • 6.8.2 Bayer AG Description and Business Overview
    • 6.8.3 Bayer AG Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Bayer AG Product Portfolio
    • 6.8.5 Bayer AG Recent Developments/Updates
  • 6.9 Johnson & Johnson Services Inc.
    • 6.9.1 Johnson & Johnson Services Inc. Corporation Information
    • 6.9.2 Johnson & Johnson Services Inc. Description and Business Overview
    • 6.9.3 Johnson & Johnson Services Inc. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Johnson & Johnson Services Inc. Product Portfolio
    • 6.9.5 Johnson & Johnson Services Inc. Recent Developments/Updates
  • 6.10 Teva Pharmaceutical Industries Ltd.
    • 6.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
    • 6.10.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
    • 6.10.3 Teva Pharmaceutical Industries Ltd. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Teva Pharmaceutical Industries Ltd. Product Portfolio
    • 6.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 6.11 Eli Lily and Company
    • 6.11.1 Eli Lily and Company Corporation Information
    • 6.11.2 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Description and Business Overview
    • 6.11.3 Eli Lily and Company Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Eli Lily and Company Product Portfolio
    • 6.11.5 Eli Lily and Company Recent Developments/Updates
  • 6.12 Sanofi S.A.
    • 6.12.1 Sanofi S.A. Corporation Information
    • 6.12.2 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Description and Business Overview
    • 6.12.3 Sanofi S.A. Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Sanofi S.A. Product Portfolio
    • 6.12.5 Sanofi S.A. Recent Developments/Updates
  • 6.13 Takeda Pharmaceutical Company Limited
    • 6.13.1 Takeda Pharmaceutical Company Limited Corporation Information
    • 6.13.2 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Description and Business Overview
    • 6.13.3 Takeda Pharmaceutical Company Limited Autoimmune Disorder Drug Delivery Device Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Takeda Pharmaceutical Company Limited Product Portfolio
    • 6.13.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates

7 Autoimmune Disorder Drug Delivery Device Manufacturing Cost Analysis

  • 7.1 Autoimmune Disorder Drug Delivery Device Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Autoimmune Disorder Drug Delivery Device
  • 7.4 Autoimmune Disorder Drug Delivery Device Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Autoimmune Disorder Drug Delivery Device Distributors List
  • 8.3 Autoimmune Disorder Drug Delivery Device Customers

9 Autoimmune Disorder Drug Delivery Device Market Dynamics

  • 9.1 Autoimmune Disorder Drug Delivery Device Industry Trends
  • 9.2 Autoimmune Disorder Drug Delivery Device Growth Drivers
  • 9.3 Autoimmune Disorder Drug Delivery Device Market Challenges
  • 9.4 Autoimmune Disorder Drug Delivery Device Market Restraints

10 Global Market Forecast

  • 10.1 Autoimmune Disorder Drug Delivery Device Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Autoimmune Disorder Drug Delivery Device by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Autoimmune Disorder Drug Delivery Device by Type (2022-2027)
  • 10.2 Autoimmune Disorder Drug Delivery Device Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Autoimmune Disorder Drug Delivery Device by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Autoimmune Disorder Drug Delivery Device by Application (2022-2027)
  • 10.3 Autoimmune Disorder Drug Delivery Device Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Autoimmune Disorder Drug Delivery Device by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Autoimmune Disorder Drug Delivery Device by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Pen Injectors
    Auto-Injectors
    Prefilled Syringes
    Vials

    Segment by Application
    In-house Manufacturing
    Outsourced Manufacturing

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    AbbVie Inc.
    Amgen Inc.
    F. Hoffmann- La Roche Ltd.
    Novartis AG
    GlaxoSmithKline Plc
    Biogen Inc.
    Merck KGaA
    Bayer AG
    Johnson & Johnson Services Inc.
    Teva Pharmaceutical Industries Ltd.
    Eli Lily and Company
    Sanofi S.A.
    Takeda Pharmaceutical Company Limited

    Buy now